| 000 | 01391 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513214817.0 | ||
| 264 | 0 | _c20000901 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0960-3271 | ||
| 024 | 7 |
_a10.1191/096032700678815855 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlack, L E | |
| 245 | 0 | 0 |
_aSafety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies? _h[electronic resource] |
| 260 |
_bHuman & experimental toxicology _cApr 2000 |
||
| 300 |
_a205-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadverse effects |
| 650 | 0 | 4 | _aBiopharmaceutics |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 700 | 1 | _aGreen, J D | |
| 700 | 1 | _aRener, J | |
| 700 | 1 | _aDayan, A | |
| 700 | 1 | _aCavagnaro, J A | |
| 700 | 1 | _aSpindler, P | |
| 700 | 1 | _aBussiere, J L | |
| 700 | 1 | _aBouchard, P | |
| 700 | 1 | _aInoue, T | |
| 700 | 1 | _aThomas, P T | |
| 700 | 1 | _aEssayan, D M | |
| 700 | 1 | _aGillett, N A | |
| 700 | 1 | _aHart, T K | |
| 700 | 1 | _aHastings, K | |
| 700 | 1 | _aHouse, R V | |
| 700 | 1 | _aLatta, D | |
| 700 | 1 | _aLiminga, U | |
| 700 | 1 | _aTreacy, G | |
| 700 | 1 | _aWierda, D | |
| 773 | 0 |
_tHuman & experimental toxicology _gvol. 19 _gno. 4 _gp. 205-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1191/096032700678815855 _zAvailable from publisher's website |
| 999 |
_c10868179 _d10868179 |
||